Bill Meant To Tell Consumers Where Drugs Were Made Is Weakened Ahead Of Senate Vote

Bill Meant To Tell Consumers Where Drugs Were Made Is Weakened Ahead Of Senate Vote The Clear Labels Act was introduced earlier this year by Sens. Rick Scott (R-Fla.) and Kirsten Gillibrand (D-N.Y.). ProPublica reported that in the wake of some key safety provisions being dropped ahead of a full Senate vote, experts worry that the legislation would be less effective. https://kffhealthnews.org/morning-breakout/pharma-and-tech-092126/